Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of associating genetic variants with a clinical outcome in patients suffering from age-related macular degeneration treated with anti-VEGF

Methods of associating genetic variants with a clinical outcome in patients suffering from age-related macular degeneration treated with anti-VEGF

US Patent 12116622 · Granted Oct 15, 2024

Estimated economic value: $151,983,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of sepsis with PCSK9 and LDLR modulators2025
Gait analysis system2025
Genome-based methods for reducing cardiovascular risk2025
Methods of treating allergy using anti-Bet v 1 antibodies2024
Methods of associating genetic variants with a clinical outcome in patients suff2023
Methods of associating genetic variants with a clinical outcome in patients suff2023
Methods of associating genetic variants with a clinical outcome in patients suff2023
Methods of associating genetic variants with a clinical outcome in patients suff2022
Methods of associating genetic variants with a clinical outcome in patients suff2022
Methods of associating genetic variants with a clinical outcome in patients suff2022
Methods for evaluating osteoarthritis risk2010